Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity
Autor: | James Cantley, Dorit Samocha-Bonet, P. Tess Whitworth, Daniel J. Fazakerley, David E. James, Lindsay E. Wu, Trevor J. Biden, Nigel Turner |
---|---|
Přispěvatelé: | Fazakerley, Daniel [0000-0001-8241-2903], Apollo - University of Cambridge Repository |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment BMI body mass index FABP4 SILAC stable-isotope labelling by amino acids in cell culture Adipokine T2D type 2 diabetes Type 2 diabetes Biology cAMP cyclic-AMP Brief Communication Fatty acid-binding protein GSIS glucose-stimulated insulin secretion chemistry.chemical_compound Insulin resistance Internal medicine Adipocyte Insulin receptor substrate medicine Obesity Molecular Biology IBMX 3-Isobutyl-1-methylxanthine NEFA non-esterified fatty acid Insulin Insulin secretion Beta-cell Cell Biology medicine.disease Endocrinology chemistry ELISA enzyme-linked immunosorbant assay Beta cell |
Zdroj: | Molecular Metabolism |
DOI: | 10.17863/cam.56860 |
Popis: | A critical feature of obesity is enhanced insulin secretion from pancreatic β-cells, enabling the majority of individuals to maintain glycaemic control despite adiposity and insulin resistance. Surprisingly, the factors coordinating this adaptive β-cell response with adiposity have not been delineated. Here we show that fatty acid binding protein 4 (FABP4/aP2) is an adipokine released from adipocytes under obesogenic conditions, such as hypoxia, to augment insulin secretion. The insulinotropic action of FABP4 was identified using an in vitro system that recapitulates adipocyte to β-cell endocrine signalling, with glucose-stimulated insulin secretion (GSIS) as a functional readout, coupled with quantitative proteomics. Exogenous FABP4 potentiated GSIS in vitro and in vivo, and circulating FABP4 levels correlated with GSIS in humans. Insulin inhibited FABP4 release from adipocytes in vitro, in mice and in humans, consistent with feedback regulation. These data suggest that FABP4 and insulin form an endocrine loop coordinating the β-cell response to obesity. Graphical abstract |
Databáze: | OpenAIRE |
Externí odkaz: |